Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...

Perhaps you’re wondering: with its innovative technology, can Cardano’s ADA reach new all-time highs soon? Let’s uncover what the future holds for Cardano. Based on the 1-day chart for Cardano (ADA), ...

For the next 7 days, ADA could trade between a minimum of $0.58 and a maximum of $1.09, reflecting potential short-term fluctuations. Depending on market sentiment and ecosystem developments, the ...